AI promised to speed up drug discovery, but the real bottleneck is in clinical trials. This startup is using AI to accelerate ...

Outsourcing is driving biopharma efficiency and scale, including in the drug discovery area and early phase development.

AstraZeneca's $15 billion pledge to its China operations highlights the country's advantages. But other regions are also hoping to host more clinical studies.

The FDA Center for Drug Evaluation and Research has accepted a letter of intent for the first biomarker for idiopathic ...

LIBERTY is part of the Company’s broader REVOLUTION clinical program designed to elaborate the profile of monoclonal antibody-mediated ...

Replacing animal testing with alternate methodologies in preclinical drug trials holds potential for the development of ...

The West Virginia House of Delegates and Mississippi House of Representatives have both approved bills to support research in ...

The U.S. FDA has granted fast track status to pelareorep combination therapy for some KRAS-mutant, microsatellite-stable metastatic colorectal cancers.

NTLA stock faces binary risk: success could unlock multi-billion dollar markets, while setbacks may erase hundreds of ...

An experimental pill called enlicitide slashed levels of low-density lipoprotein (LDL) cholesterol, commonly known as "bad" ...

If the FDA follows through with the proposed guidelines, and they are not fatally twisted by pressure from the medical ...

February 2, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced ...